References
- Centers for Disease Control and Prevention [Internet] Atlanta, GA Centers for Disease Control and Prevention, U.S. Department of Health and Human Services 2017 National Diabetes Statistics Report, 2017; 2017 [cited 2018 Jul 2]. Available from: https://www.cdc.gov/diabetes/data/statistics-report/index.html
- American Diabetes Association Classification and Diagnosis of Diabetes Diabetes Care 2017 Jan 40 Suppl 1 S11 S24
- World Health Organization [Internet] Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation Geneva, Switzerland World Health Organization 2006 [cited 2018 Aug 6]. Available from: http://www.who.int/diabetes/publications/Definitionanddiagnosisofdiabetes_new.pdf
- Huang Y Cai X Mai W Li M Hu Y Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis BMJ 2016 Nov 23 355 i5953
- Nasr G Sliem H Silent myocardial ischemia in prediabetics in relation to insulin resistance J Cardiovasc Dis Res 2010 Jul 1 3 116 21
- Levitan EB Song Y Ford ES Liu S Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies Arch Intern Med 2004 Oct 25 164 19 2147 55
- Isordia-Salas I Galván-Plata ME Leaños-Miranda A Proinflammatory and prothrombotic state in subjects with different glucose tolerance status before cardiovascular disease J Diabetes Res 2014 2014 631902
- Bembde AS A study of plasma fibrinogen level in type-2 diabetes mellitus and its relation to glycemic control Indian J Hematol Blood Transfus 2012 Jun 28 2 105 8
- Sen K Mukherjee AK Dharchowdhury L Chatterjee A A study to find out the proportion of prediabetes in patients with acute coronary syndrome in a medical college of Kolkata J Indian Med Assoc 2008 Dec 106 12 776 8
- Kurihara O Takano M Yamamoto M Impact of prediabetic status on coronary atherosclerosis: a multivessel angioscopic study Diabetes Care 2013 Mar 36 3 729 33
- Scicali R Giral P Gallo A HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non-diabetic patients Atherosclerosis 2016 Dec 255 102 8
- Mahmood SS Wang TJ The epidemiology of congestive heart failure: the Framingham Heart Study perspective Glob Heart 2013 Mar 1 8 1 77 82
- Koncsos G Varga ZV Baranyai T Diastolic dysfunction in prediabetic male rats: Role of mitochondrial oxidative stress Am J Physiol Heart Circ Physiol 2016 Oct 1 311 4 H927 H943
- Essop MF Anna Chan WY Valle A García-Palmer FJ Du Toit EF Impaired contractile function and mitochondrial respiratory capacity in response to oxygen deprivation in a rat model of prediabetes Acta Physiol (Oxf) 2009 Dec 197 4 289 96
- Di Pino A Mangiafico S Urbano F HbA1c Identifies Subjects With Pre-diabetes and Subclinical Left Ventricular Diastolic Dysfunction J Clin Endocrinol Metab 2017 Oct 1 102 10 3756 64
- Lindström J Louheranta A Mannelin M Finnish Diabetes Prevention Study Group The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity Diabetes Care 2003 Dec 26 12 3230 6
- Lindström J Ilanne-Parikka P Peltonen M Finnish Diabetes Prevention Study Group Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study Lancet 2006 Nov 11 368 9548 1673 9
- Diabetes Prevention Program (DPP) Research Group The Diabetes Prevention Program (DPP): description of lifestyle intervention Diabetes Care 2002 Dec 25 12 2165 71
- Hamman RF Wing RR Edelstein SL Effect of weight loss with lifestyle intervention on risk of diabetes Diabetes Care 2006 Sep 29 9 2102 7
- Katula JA Vitolins MZ Rosenberger EL One-year results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project Diabetes Care 2011 Jul 34 7 1451 7
- Klein S Sheard NF Pi-Sunyer X American Diabetes Association; North American Association for the Study of Obesity; American Society for Clinical Nutrition Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr 2004 Aug 80 2 257 63
- Garber AJ Abrahamson MJ Barzilay JI CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY Endocr Pract 2018 Jan 24 1 91 120
- Rena G Hardie DG Pearson ER The mechanisms of action of metformin Diabetologia 2017 Sep 60 9 1577 85
- Salpeter SR Buckley NS Kahn JA Salpeter EE Meta-analysis: metformin treatment in persons at risk for diabetes mellitus Am J Med 2008 Feb 121 2 149 157.e2
- Ramachandran A Snehalatha C Mary S The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) Diabetologia 2006 Feb 49 2 289 97
- Svensson E Baggesen LM Johnsen SP Early Glycemic Control and Magnitude of HbA1c Reduction Predict Cardiovascular Events and Mortality: Population-Based Cohort Study of 24,752 Metformin Initiators Diabetes Care 2017 Jun 40 6 800 7
- Smith U Pioglitazone: mechanism of action Int J Clin Pract Suppl 2001 Sep 121 13 8
- DeFronzo RA Tripathy D Schwenke DC Pioglitazone for diabetes prevention in impaired glucose tolerance N Engl J Med 2011 Mar 24 364 12 1104 15
- Kernan WN Viscoli CM Furie KL Pioglitazone after Ischemic Stroke or Transient Ischemic Attack N Engl J Med 2016 Apr 7 374 14 1321 31
- Chiasson JL Josse RG Gomis R Hanefeld M Karasik A Laakso M STOP-NIDDM Trail Research Group Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial Lancet 2002 Jun 15 359 9323 2072 7
- Chiasson JL Josse RG Gomis R Hanefeld M Karasik A Laakso M STOP-NIDDM Trial Research Group Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial JAMA 2003 Jul 23 290 4 486 94
- Russell-Jones D Vaag A Schmitz O Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial Diabetologia 2009 Oct 52 10 2046 55
- le Roux CW Astrup A Fujioka K SCALE Obesity Prediabetes NN8022-1839 Study Group 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial Lancet 2017 389 10077 1399 1409
- Marso SP Daniels GH Brown-Frandsen K Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes N Engl J Med 2016 Jul 28 375 4 311 22
- Guerciolini R Mode of action of orlistat Int J Obes Relat Metab Disord 1997 Jun 21 Suppl 3 S12 23
- Torgerson JS Hauptman J Boldrin MN Sjöström L XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients Diabetes Care 2004 Jan 27 1 155 61
-
Lonneman
DJ
Jr Rey JA McKee BD Phentermine/Topiramate extended-release capsules (qsymia) for weight loss P T 2013 Aug 38 8 446 52 - Guo F Garvey WT Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release Diabetes Care 2017 Jul 40 7 856 62
- Gustafson A King C Rey JA Lorcaserin (Belviq): A Selective Serotonin 5-HT2C Agonist In the Treatment of Obesity P T 2013 Sep 38 9 525 34
- Nesto R Fain R Li Y Shanahan W Evaluation of lorcaserin on progression of prediabetes to type 2 diabetes and reversion to euglycemia Postgrad Med 2016 May 128 4 364 70
- de la Cruz-Muñoz N Messiah SE Arheart KL Lopez-Mitnik G Lipshultz SE Livingstone A Bariatric surgery significantly decreases the prevalence of type 2 diabetes mellitus and prediabetes among morbidly obese multiethnic adults: long-term results J Am Coll Surg 2011 Apr 212 4 505 11 discussion 512–3
- Keidar A Bariatric surgery for type 2 diabetes reversal: the risks Diabetes Care 2011 May 34 Suppl 2 S361 266
- Carlsson LMS Sjöholm K Karlsson C Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study Lancet Diabetes Endocrinol 2017 Apr 5 4 271 9
DOI: https://doi.org/10.14797/mdcj-14-4-289 | Journal eISSN: 1947-6108
Language: English
Page range: 289 - 297
Published on: Oct 1, 2018
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2018 Ashkan Zand, Karim Ibrahim, Bhargavi Patham, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.